| Name | palmitoyl-l-carnitine chloride |
|---|---|
| Synonyms |
MFCD00070346
Palmitoyl-L-carnitine chloride 3-carboxy-n,n,n-trimethyl-2-(palmitoyloxy)propan-1-aminium chloride UNII:EIL57224QR 1-Propanaminium, 3-carboxy-N,N,N-trimethyl-2-[(1-oxohexadecyl)oxy]-, chloride (1:1) EINECS 242-642-6 3-Carboxy-N,N,N-trimethyl-2-(palmitoyloxy)-1-propanaminium chloride |
| Description | L-Palmitoylcarnitine chloride, a long-chain acylcarnitine and a fatty acid metabolite, accumulates in the sarcolemma and deranges the membrane lipid environment during ischaemia. L-Palmitoylcarnitine chloride inhibits KATP channel activity, without affecting the single channel conductance, through interaction with Kir6.2[1]. |
|---|---|
| Related Catalog | |
| Target |
Kir6.2 Human Endogenous Metabolite |
| In Vitro | L-Palmitoylcarnitine (1 µM) inhibits KATP channel activity, without affecting the single channel conductance, through interaction with Kir6.2. L-Palmitoylcarnitine simultaneously enhances the ATP sensitivity of the channel (IC50 fell from 62 to 30 µM)[1]. Modulation of the membrane lipid environment caused by L-Palmitoylcarnitine alters the KATP channel function mainly through the interaction with endogenous PI cascade, especially PIP2[1]. |
| References |
| Melting Point | 168-172ºC(lit.) |
|---|---|
| Molecular Formula | C23H46ClNO4 |
| Molecular Weight | 436.069 |
| Exact Mass | 435.311523 |
| PSA | 63.60000 |
| LogP | 2.56440 |
| Storage condition | -20°C |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi: Irritant; |
| Risk Phrases | R36/37/38 |
| Safety Phrases | 26-36 |
| RIDADR | NONH for all modes of transport |